DelveInsight Business Research LLP

DelveInsight’s “Bronchiectasis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Bronchiectasis, historical and forecasted epidemiology as well as the Bronchiectasis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Bronchiectasis Overview

Bronchiectasis is a long-term condition where the airways of the lungs become widened, leading to a build-up of excess mucus that can make the lungs more vulnerable to infection. The most common symptoms of bronchiectasis include: a persistent cough that usually brings up phlegm (sputum)

Bronchiectasis Epidemiology Insights

The prevalence of bronchiectasis increases with age with an 8- to 10-fold difference in prevalence after the age of 60 years (300 to 500 per 100,000) as compared to ages

Click here to learn more about the Bronchiectasis Market Landscape

The Report Covers the Bronchiectasis Epidemiology Segmented by:

• Total Bronchiectasis incident cases 

• Total Bronchiectasis prevalent cases 

• Total Bronchiectasis treatment cases 

• Total Bronchiectasis diagnostic cases 

Bronchiectasis Market Outlook 

The Bronchiectasis market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Bronchiectasis market trends by analyzing the impact of current Bronchiectasis therapies on the market, unmet needs, drivers and barriers, and demand for better technology. This segment gives a thorough detail of Bronchiectasis market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Bronchiectasis market data are presented with relevant tables and graphs to give a clear view of the market at first sight. According to DelveInsight, the Bronchiectasis market in 7MM is expected to witness a major change in the study period 2019-2032.

Key Companies Working in the Bronchiectasis Market

• Novartis

• AstraZeneca

• Thirty Respiratory Limited

• RedHill Biopharma Limited

• Kyowa Kirin

• Chiesi Pharmaceuticals

• And many others.

Bronchiectasis Therapies Covered and Analyzed in the Report:

• Erythromycin

•  Macrolides

• Azithromycin

• BI 1291583

• Formoterol-beclomethasone

• BI 1291583

• Roflumilast

• Fluroquinolones

And many others 

Learn more about the Key Companies and Emerging Therapies in the Bronchiectasis Market

Table of Contents 

1. Key Insights 

2. Bronchiectasis  Introduction 

3. Executive Summary of Bronchiectasis         

4. Disease Background and Overview

5. Epidemiology and patient population

6. Bronchiectasis  Emerging Therapies

7. Bronchiectasis  Market Outlook

8. Market Access and Reimbursement of Therapies

9. Market Drivers 

10. Market Barriers 

11. Appendix

12. Report Methodology

13. DelveInsight Capabilities

14. Disclaimer

Learn about the detailed offerings of the report @ Bronchiectasis Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services